Lundbeck
HLUN-B.CO
#2431
Rank
NZ$10.31 B
Marketcap
$10.81
Share price
-0.13%
Change (1 day)
33.47%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Cash on Hand

Cash on Hand as of June 2024 : NZ$1.50 Billion

According to Lundbeck 's latest financial reports the company has NZ$1.50 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lundbeck - Cash on Hand chart (from 2009 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$1.17 B51.21%
2022-12-31NZ$0.77 B52.75%
2021-12-31NZ$0.50 B-43.49%
2020-12-31NZ$0.89 B34.06%
2019-12-31NZ$0.67 B-55.75%
2018-12-31NZ$1.51 B81.57%
2017-12-31NZ$0.83 B84.18%
2016-12-31NZ$0.45 B39.15%
2015-12-31NZ$0.32 B-57.42%
2014-12-31NZ$0.76 B-42.06%
2013-12-31NZ$1.32 B61.08%
2012-12-31NZ$0.81 B-6.89%
2011-12-31NZ$0.88 B62.04%
2010-12-31NZ$0.54 B1.43%
2009-12-31NZ$0.53 B-57.31%
2008-12-31NZ$1.25 B177.04%
2007-12-31NZ$0.45 B52.88%
2006-12-31NZ$0.29 B179.06%
2005-12-31NZ$0.10 B-23.23%
2004-12-31NZ$0.13 B